Tokyo, Dec. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060032) titled 'Investigation of abemaciclib-induced diarrhea during the second and third cycles of abemaciclib' on Dec. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Yokohama Asahi Chuo General Hospital
Condition:
Condition - Hormone Receptor-Positive, HER2-Negative Breast Cancer (Advanced/Recurrent or Adjuvant)
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to describe the occurrence of abemaciclib-induced diarrhea (AID) and the actual use of loperamide during the second and third cycles of abemaciclib in patients with hormone re...